Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-11-17FDA Approved: RIVASTIGMINE TARTRATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for rivastigmine tartrate from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2015-11-17FDA Approved: GALANTAMINE HYDROBROMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for galantamine hydrobromide submitted by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2015-11-17FDA Approved: RIVASTIGMINE TARTRATE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for rivastigmine tartrate submitted by Alembic Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: Safety Study of MT-4666 in Subjects With Alzheimer's Disease [Phase 3]
Phase 3 safety study of MT-4666 in Alzheimer's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-11-11Clinical Trial Update: Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]
A completed Phase 2, double-blind, placebo-controlled study evaluating oral dimebon (latrepirdine) in individuals with mild to moderate Alzh…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-11-10Clinical Trial Update: Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil [Phase 1]
Phase 1 safety and tolerability study of Dimebon in Alzheimer's disease patients. It evaluated Dimebon in combination with memantine and wit…
-
CLINICAL_TRIALS trial_result · 2015-11-09Clinical Trial Update: Pharmacokinetic Properties of Idalopirdine (Lu AE58054) in Subjects With and Without Impaired Kidney Function [Phase 1]
Phase 1 pharmacokinetic study evaluating the effect of kidney impairment on exposure to idalopirdine (Lu AE58054) in subjects with and witho…
-
CLINICAL_TRIALS trial_result · 2015-11-05Clinical Trial Update: Evaluating Simvastatin's Potential Role in Therapy [Phase 2]
Phase 2 trial investigating simvastatin for Alzheimer disease has completed with results posted.
-
FDA approval · 2015-10-30FDA Approved: FLUDEOXYGLUCOSE F18 — Original Application (3D Imaging Drug Design and Development LLC)
FDA approved Fluorodeoxyglucose F18 (FDG F-18) as an original radiopharmaceutical for PET imaging to assess metabolic activity in oncology, …
-
FDA approval · 2015-10-30FDA Approved: DONEPEZIL HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' generic donepezil hydrochloride (ANDA original application) for the treatment of mild, moderate, and sev…
-
FDA approval · 2015-10-27FDA Approved: FLUDEOXYGLUCOSE F 18 — Original Application (Kettering Medical Center)
FDA approved Fludeoxyglucose F-18 (FDG F-18) under an Original Application by Kettering Medical Center for use as a PET imaging radiopharmac…
-
FDA approval · 2015-10-26FDA Approved: GALANTAMINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for galantamine submitted by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS withdrawal · 2015-10-26Clinical Trial Update: Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT) [Phase 4]
This Phase 4 clinical trial comparing Cerebrolysin to Donepezil in patients with mild to moderate Alzheimer's disease was withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-10-23Clinical Trial Update: A Study of the Safety, Tolerability, and Pharmacodynamics of MK-8931 in Participants With Alzheimer's Disease (MK-8931-010 AM1 [P07820 AM1]) [Phase 1]
This completed Phase 1 study evaluated the safety, tolerability, and pharmacodynamics of verubecestat (MK-8931) in participants with Alzheim…
-
CLINICAL_TRIALS research · 2015-10-23Clinical Trial Update: Early-onset and Late-onset Sporadic Alzheimer's Disease (AD) [NA]
This clinical trial entry concerns early-onset and late-onset sporadic Alzheimer's disease, with the status listed as unknown.
-
CLINICAL_TRIALS trial_result · 2015-10-19Clinical Trial Update: Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients. [Phase 2]
Phase 2 clinical trial update evaluating the safety and cognitive/memory effects of intranasal insulin glulisine in patients with mild-to-mo…
-
CLINICAL_TRIALS withdrawal · 2015-10-15Clinical Trial Update: Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine [Phase 2]
Phase 2 study evaluating the safety of two doses of EVP-6124 in people with Alzheimer's disease who are receiving memantine has been withdra…
-
FDA approval · 2015-10-13FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved memantine hydrochloride from Alembic Pharmaceuticals Limited under an original ANDA.
-
FDA approval · 2015-10-13FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original ANDA for memantine hydrochloride from Aurobindo Pharma Limited, a generic version of memantine used to treat Alzhe…
-
FDA approval · 2015-10-13FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
The FDA approved the original application for memantine hydrochloride tablets from Macleods Pharmaceuticals Limited, a generic version indic…
-
FDA approval · 2015-10-13FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved the original application for a generic memantine hydrochloride product from Unichem Pharmaceuticals (USA), Inc. for the tre…
-
FDA approval · 2015-10-13FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved an original ANDA for memantine hydrochloride from Macleods Pharmaceuticals Limited. The drug is used to treat Alzheimer's disea…
-
FDA approval · 2015-10-13FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Chartwell Governmental & Specialty RX, LLC.)
The FDA approved memantine hydrochloride under an original ANDA filed by Chartwell Governmental & Specialty RX, LLC.
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
Phase II randomized, double-blind, placebo-controlled study assessing the safety and tolerability of BMS-708163 in patients with mild to mod…
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease [Phase 1]
A Phase 1 safety study of AADvac1, a tau peptide-KLH-conjugate active vaccine, for Alzheimer's disease has completed.